Ye‐Xuan Cao

2.4k total citations
69 papers, 1.5k citations indexed

About

Ye‐Xuan Cao is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ye‐Xuan Cao has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 29 papers in Cardiology and Cardiovascular Medicine and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ye‐Xuan Cao's work include Lipoproteins and Cardiovascular Health (36 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Cancer, Lipids, and Metabolism (11 papers). Ye‐Xuan Cao is often cited by papers focused on Lipoproteins and Cardiovascular Health (36 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Cancer, Lipids, and Metabolism (11 papers). Ye‐Xuan Cao collaborates with scholars based in China, Brazil and United States. Ye‐Xuan Cao's co-authors include Jian‐Jun Li, Na‐Qiong Wu, Cheng‐Gang Zhu, Huihui Liu, Yuan‐Lin Guo, Jing‐Lu Jin, Huiwen Zhang, Ying Gao, Qiu‐Ting Dong and Di Sun and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Ye‐Xuan Cao

66 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ye‐Xuan Cao China	22	759	633	580	321	197	69	1.5k
Qian Dong China	22	663 0.9×	514 0.8×	413 0.7×	239 0.7×	165 0.8×	80	1.3k
Jing‐Lu Jin China	21	616 0.8×	551 0.9×	502 0.9×	305 1.0×	139 0.7×	54	1.2k
Jeong‐Gun Park United States	18	1.0k 1.4×	587 0.9×	425 0.7×	244 0.8×	173 0.9×	59	1.6k
Sander I. van Leuven Netherlands	20	683 0.9×	449 0.7×	448 0.8×	197 0.6×	190 1.0×	45	1.8k
Laura D’Erasmo Italy	24	511 0.7×	565 0.9×	541 0.9×	395 1.2×	221 1.1×	70	1.3k
Di Sun China	17	435 0.6×	387 0.6×	391 0.7×	161 0.5×	143 0.7×	49	962
Lulu Ren Sterling United States	16	961 1.3×	419 0.7×	368 0.6×	144 0.4×	247 1.3×	21	2.2k
Marcelo Costa Batista Brazil	19	523 0.7×	222 0.4×	449 0.8×	217 0.7×	170 0.9×	69	1.3k
In Suck Choi South Korea	17	473 0.6×	598 0.9×	430 0.7×	295 0.9×	124 0.6×	49	1.3k
Jonathan Fialkow United States	12	539 0.7×	269 0.4×	247 0.4×	270 0.8×	86 0.4×	29	1.0k

Countries citing papers authored by Ye‐Xuan Cao

Since Specialization

Citations

This map shows the geographic impact of Ye‐Xuan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye‐Xuan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye‐Xuan Cao more than expected).

Fields of papers citing papers by Ye‐Xuan Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye‐Xuan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye‐Xuan Cao. The network helps show where Ye‐Xuan Cao may publish in the future.

Co-authorship network of co-authors of Ye‐Xuan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Ye‐Xuan Cao. A scholar is included among the top collaborators of Ye‐Xuan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye‐Xuan Cao. Ye‐Xuan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Shuang, et al.. (2025). Myocardial infarction with nonobstructive coronary arteries (MINOCA): a narrative review. European journal of medical research. 30(1). 443–443.

Li, Yumei, et al.. (2025). Integrating short-read and long-read single-cell RNA sequencing for comprehensive transcriptome profiling in mouse retina. Genome Research. 35(4). 740–754.

Deng, Li, et al.. (2023). Aortic Dissection Detection Risk Score and D-Dimer for Acute Aortic Syndromes in the Chinese Population: Exploration of Optimal Thresholds and Integrated Diagnostic Value. Journal of Cardiovascular Translational Research. 16(4). 886–895. 4 indexed citations

Chen, Bo, et al.. (2023). Case report: obstruction in the right ventricular outflow tract due to hemolymphangioma. Frontiers in Cardiovascular Medicine. 10. 1142970–1142970. 1 indexed citations

Peng, Jia, Mingming Liu, Jing‐Lu Jin, et al.. (2022). NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study. Lipids in Health and Disease. 21(1). 3–3. 8 indexed citations

Liu, Huihui, Ye‐Xuan Cao, Jing‐Lu Jin, et al.. (2021). Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study. Cardiovascular Diabetology. 20(1). 84–84. 20 indexed citations

Jin, Jing‐Lu, Huiwen Zhang, Ye‐Xuan Cao, et al.. (2021). Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease. Hepatology International. 15(2). 413–423. 38 indexed citations

Zhang, Huiwen, Jing‐Lu Jin, Ye‐Xuan Cao, et al.. (2021). Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovascular Diabetology. 20(1). 214–214. 14 indexed citations

Liu, Huihui, Ye‐Xuan Cao, Jing‐Lu Jin, et al.. (2021). Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study. Hepatology International. 15(6). 1337–1346. 21 indexed citations

10.

Liu, Huihui, Ye‐Xuan Cao, Jing‐Lu Jin, et al.. (2021). Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease. Hypertension Research. 44(9). 1158–1167. 21 indexed citations

11.

Cao, Ye‐Xuan, Huiwen Zhang, Jing‐Lu Jin, et al.. (2020). Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease. Journal of Lipid Research. 61(9). 1254–1262. 27 indexed citations

12.

Cao, Ye‐Xuan, Huiwen Zhang, Jing‐Lu Jin, et al.. (2020). Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study. Thrombosis and Haemostasis. 121(9). 1161–1168. 16 indexed citations

13.

Zhang, Minghua, Ye‐Xuan Cao, Liguo Wu, et al.. (2020). Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus. BMC Endocrine Disorders. 20(1). 156–156. 18 indexed citations

14.

Liu, Huihui, Ye‐Xuan Cao, Jing‐Lu Jin, et al.. (2020). Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease. Heart. 106(16). 1228–1235. 30 indexed citations

15.

Jin, Jing‐Lu, Di Sun, Ye‐Xuan Cao, et al.. (2019). IMPACT OF HYPERTENSION ON THE PREDICTIVE VALUE OF HEMOGLOBIN GLYCATION INDEX ON CARDIOVASCULAR OUTCOMES. Journal of the American College of Cardiology. 73(9). 272–272. 2 indexed citations

16.

Cao, Ye‐Xuan, Sha Li, Huihui Liu, & Jian‐Jun Li. (2018). Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 8(9). e022348–e022348. 59 indexed citations

17.

Dong, Qiu‐Ting, Ying Gao, Na‐Qiong Wu, et al.. (2018). Impact of glucose and lipid markers on the correlation of calculated and enzymatic measured low‐density lipoprotein cholesterol in diabetic patients with coronary artery disease. Journal of Clinical Laboratory Analysis. 32(5). e22399–e22399. 1 indexed citations

18.

Sun, Dianjun, Ye‐Xuan Cao, Na‐Qiong Wu, et al.. (2018). Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes. Journal of Endocrinological Investigation. 42(5). 591–598. 13 indexed citations

19.

Cao, Ye‐Xuan, Na‐Qiong Wu, Di Sun, et al.. (2018). Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease. Journal of Translational Medicine. 16(1). 345–345. 28 indexed citations

20.

Cao, Ye‐Xuan, Huihui Liu, Qiu‐Ting Dong, Sha Li, & Jian‐Jun Li. (2018). Effect of proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: A systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 20(6). 1391–1398. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact